Latest Market Growth News

PainChek appoints seasoned US medtech executive Karen Holzberger as CEO to spearhead growth following FDA clearance and major US contracts.

NH3 Clean Energy (ASX:NH3) has updated investors on its WAH2 Project, aiming for commercial operations by 2030 to produce low-emissions ammonia for Asia-Pacific markets. The presentation highlights strategic advantages, partnerships, and a phased development plan amid ongoing contract and financing negotiations.

Immuron Limited reported a 6% increase in FY26 sales to AUD 7.7 million, driven by strong gains in Canada and the US despite mixed Australian performance. Marketing initiatives and retail expansion underpin growth.

PainChek announces the immediate departure of CEO Philip Daffas, with COO Andy Hoggan stepping in as interim leader amid a strategic pivot to boost US market growth following FDA clearance.

Livium is positioning its Envirostream subsidiary to capitalise on the growing battery recycling needs from Australia's booming AI data centre sector, leveraging its EPA-licensed facilities and national network.

AoFrio Limited has successfully closed a renounceable pro-rata rights issue, securing NZ$4.428 million to fund its push into US and European markets and advance AI-driven innovations in cold drink equipment.

Acrow Limited has secured $70 million through a fully underwritten two-tranche placement to acquire Ausgroup Industrial Services and Preston SuperDeck, boosting its FY27 revenue and EBITDA guidance significantly.

Iron Bear Resources (ASX:IBR) has detailed progress on its Canadian Iron Bear Project, highlighting a robust scoping study, a major joint venture with Vale, and strategic advantages in a growing direct reduction pellet market.

Noodlecake Studios, via Streamplay Studio, has secured a global multi-platform publishing deal for the anime-inspired action title 'Tiebreakers', targeting mobile, PC, and console release in late 2027. Early reveal content attracted over 175,000 views within 24 hours, underscoring strong initial interest.

ImpediMed has revamped its leadership with two new commercial roles and reported encouraging sales momentum for its SOZO device. The company is advancing clinical trials and expanding its presence in cancer survivorship, weight management, and heart health sectors.

Harvest Technology Group has appointed Veronica Bainton as CEO, signalling a sharpened focus on defence markets and scaling its Nodestream platform internationally.

Osteopore has secured Hainan FDA approval to clinically use and sell its custom orthopaedic devices at Shanghai Ruijin Hospital’s Hainan branch, marking a key step towards wider China market access. The company has scheduled its first patient surgery for June 2026.